Joint Filing AgreementJoint Filing Agreement • April 20th, 2021 • Versant Venture Capital V, L.P. • Biological products, (no disgnostic substances)
The undersigned hereby agree that a single Schedule 13D (or any amendment thereto) relating to the Ordinary Shares of VectivBio Holding AG shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13D.
Shareholders Agreement regarding VectivBio Holding AG 88 | 99Versant Venture Capital V, L.P. • April 20th, 2021 • Biological products, (no disgnostic substances)
Joint Filing AgreementJoint Filing Agreement • February 16th, 2021 • Versant Venture Capital V, L.P. • Biological products, (no disgnostic substances)
We, the undersigned, hereby express our agreement that the attached Schedule 13G (or any amendments thereto) relating to the Common Stock of Gritstone Oncology, Inc. is filed on behalf of each of us.
JOINT FILING AGREEMENTJoint Filing Agreement • August 3rd, 2023 • Versant Venture Capital V, L.P. • Biological products, (no disgnostic substances)
The undersigned hereby agree that the foregoing statement on Schedule 13D is filed on behalf of each of the undersigned, and any amendments thereto executed by the undersigned shall be filed on behalf of each of the undersigned without the necessity of filing any additional joint filing agreement. The undersigned acknowledge that each is responsible for the timely filing of such statement on Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning him, her or it contained therein, but shall not be responsible for the completeness or accuracy of the information concerning the others of the undersigned, except to the extent that he, she or it knows or has reason to believe that such information is inaccurate or incomplete. This Joint Filing Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
